This compound is a protected polyether intermediate featuring multiple silyl-ether groups and a complex fused-ring system, designed for use in the stereocontrolled synthesis of structurally elaborate polyether natural products. It serves as a building block in pharmaceutical research and development, particularly for constructing molecules with intricate oxygen-containing ring frameworks.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 871360-42-8
Trans-1-Cinnamylpiperazine
pharmaceutical intermediate
3-bromothiophene
pharmaceutical intermediate
5-Fluoropyridin-3-ylboronic acid
pharmaceutical intermediate
D-Propargylglycine
pharmaceutical intermediate
(1R,3S,5R,6R,7S,11R,14S,15S,16S,17R,18S,19S,20Z,22R,25S,28S,31S,33R)-5-[(2S)-2,3-bis[[tert-butyl(dimethyl)silyl]oxy]propyl]-16,17,19-tris[[tert-butyl(dimethyl)silyl]oxy]-22-hydroxy-6-methoxy-33-methyl-27,34-dimethylidene-4,35,36,37,38-pentaoxahexacyclo[29.3.1.111,15.114,18.125,28.03,7]octatriacont-20-en-9-one
OPIRHZLSIAZMNY-HEXWNEAUSA-N
C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@H](/C=C\[C@@H]([C@H]4[C@H]([C@H]([C@@H]5[C@@H](O4)CC[C@@H](O5)CC(=O)C[C@H]6[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]6OC)C[C@@H](CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O